Clinical Significance
CK-MB is found primarily in cardiac tissue.1 CK-MB can be detected at elevated concentrations following myocardial damage. Abnormal plasma CK-MB concentrations are often associated with ischemia or necrotic heart injury. The increase in CK-MB concentration is often evident within 3 to 6 hours following onset of chest pain, reaching peak concentrations within 12 to 24 hours. CK-MB concentrations will generally return to normal within 24 to 72 hours.2 The determination of CK-MB is most beneficial when samples have been drawn at appropriate time intervals post onset of chest pain.
Delivering What Matters:
- One sample, one run, one instrument; increases efficiency in triaging chest pain patients
- Rapid turnaround time - in as little as 14 min. (with onboard centrifugation)
- Single and ready to use TestPak™ Cartridges
- No reconstitution
- No warming to room temperature
- Reduction in reagent waste
- Reduction in contamination
- Heparinized whole blood samples
- Electronic QC (System Check) satisfies daily routine QC requirements permitting liquid QC flexibility
For additional information on CK-MB mass visit our educational website at
